LABU Direxion Daily S&P Biotech Bull 3X Shares
AMEXETFAs of 2026-08-24 13:57
Why LABU matters now
Direxion Daily S&P Biotech Bull 3X Shares (LABU) is a US etf in Financial Services. The latest InvestLog snapshot shows $307.59 with -3.03% on the session and $1.64B in assets/market value.
ETF Profile
Updated 2026-08-24Net Assets
$657.5M
NAV
$316.95
Expense Ratio
0.96%
Holdings
156
Issuer
Direxion
Asset Class
Leveraged/Inverse
Avg Volume
522,626
Inception
2015-05-28
Sector Exposure
Top Holdings
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 68.34% | $1.49B |
| — | GOLDMAN FINL SQ TRSRY INST 506 | 7.48% | $162.5M |
| — | DREYFUS GOVT CASH MAN INS | 2.70% | $58.6M |
| — | GOLDMAN SACHS FIN GOV 465 INSTITUT | 0.72% | $15.6M |
| MRNA | MODERNA INC | 0.55% | $12.0M |
| TWST | TWIST BIOSCIENCE CORP | 0.38% | $8.3M |
| ORKA | ORUKA THERAPEUTICS INC | 0.31% | $6.8M |
| APGE | APOGEE THERAPEUTICS INC | 0.31% | $6.7M |
| KYMR | KYMERA THERAPEUTICS INC | 0.30% | $6.4M |
| PRAX | PRAXIS PRECISION MEDICINES I | 0.29% | $6.3M |
Fund Info
Asset Type
ETF
Exchange
AMEX
Currency
USD
Issuer
Direxion
Asset Class
Leveraged/Inverse
NAV Currency
USD
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x the daily performance of the S&P Biotechnology Select Industry Index. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF was formed on May 28, 2015 and is domiciled in the United States.